Fungi as Sources of Polysaccharides for Pharmaceutical and Biomedical Applications

Research output: Chapter in Book/Report/Conference proceedingChapter

5 Citations (Scopus)


Biodegradable and biocompatible polysaccharides of fungal origin, such as cell wall polysaccharides (e.g., chitin, chitosan, glucans, mannans) and extracellular polysaccharides (EPS) (e.g., pullulan, scleroglucan), have been widely studied and proposed for a wide range of applications. Due to their properties, such polysaccharides have attracted increasing interest for pharmaceutical and biomedical applications, including in immunology and drug delivery systems. Many polysaccharides of fungal origin are currently being investigated for such uses in in-vitro and in-vivo clinical trials. Moreover, there are already several commercial fungal polysaccharides available, although most of them are marketed as natural products and their clinical use is still not widespread.

Original languageEnglish
Title of host publicationHandbook of Polymers for Pharmaceutical Technologies
Subtitle of host publicationBiodegradable Polymers
Number of pages43
ISBN (Electronic)978-111904145-0
ISBN (Print)978-111904142-9
Publication statusPublished - 19 Sep 2015


  • Chitin
  • Chitosan
  • Fungi
  • Glucans
  • Mannans
  • Polysaccharides
  • Yeast

Fingerprint Dive into the research topics of 'Fungi as Sources of Polysaccharides for Pharmaceutical and Biomedical Applications'. Together they form a unique fingerprint.

Cite this